RxDoctor Payments Data

Jodie Chandler

Family · Murrells Inlet, SCNPI 1710671417

Payments from drug & device makers

$6,049in general payments, 2019–2025

Across 223 payments — averaging $27.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$1K
  • AstraZeneca$907
  • GSK$860
  • Insmed, Inc.$570
  • Sanofi$410
  • Regeneron Healthcare Solutions, Inc.$308
  • plus $2K from 19 others

What the payments were for

  • Travel & lodging$79013%
  • Food & beverage$5,25987%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,049 in reported general payments places this provider in the 95th percentile of 3,248 family providers in South Carolina.

See all family providers in South Carolina

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter92$62,824
Breztri AerosphereBudesonide/Glycopyr/Formoterol19$14,099
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr18$7,267
Albuterol Sulfate HfaAlbuterol Sulfate86$2,091
Prednisone78$246
Montelukast Sodium31$173
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav16$115
Levofloxacin13$95
Doxycycline Hyclate14$75
Azithromycin12$59

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Anoro Ellipta$860$70,091110 claims
AstraZenecaBreztri Aerosphere$907$14,09919 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,248 family providers in South Carolina.

Other family in Murrells Inlet

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →